Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-12 Sale |
2022-09-14 4:24 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
153,897 | $31.96 | $4,919,148 | 5,599,842 (Indirect) |
View |
| 2022-08-08 Sale |
2022-08-10 4:22 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
274,568 | $38.11 | $10,464,363 | 5,753,739 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-07 Tax Withholding |
2023-01-10 4:08 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
409 | $26.41 | 16,855 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:07 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
4,097 | $26.41 | 905,104 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:05 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
1,483 | $26.41 | 237,223 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
546 | $26.41 | 36,061 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Perier Francis I Jr Chief Financial Officer |
1,090 | $26.41 | 43,463 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,068 | $26.41 | 212,219 (Direct) |
View |
| 2023-01-07 Tax Withholding |
2023-01-10 4:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
909 | $26.41 | 35,830 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:01 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Perier Francis I Jr Chief Financial Officer |
144,425 | $0 | 169,553 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Perier Francis I Jr Chief Financial Officer |
2,374 | $27.52 | 169,553 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:01 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
344,175 | $0 | 1,169,201 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
8,400 | $27.52 | 1,169,201 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:01 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
273,994 | $0 | 478,706 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
3,326 | $27.52 | 478,706 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:00 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Cassidy James Chief Medical Officer |
157,663 | $0 | 182,230 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:00 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Cassidy James Chief Medical Officer |
1,263 | $27.52 | 182,230 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:00 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
157,663 | $0 | 348,287 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:00 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
2,452 | $27.52 | 348,287 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:00 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
74,713 | $0 | 82,264 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:00 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
783 | $27.52 | 82,264 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 5:00 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
92,663 | $0 | 115,096 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 5:00 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,665 | $27.52 | 115,096 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 4:59 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
144,425 | $0 | 161,739 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 4:59 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
1,782 | $27.52 | 161,739 (Direct) |
View |
| 2023-01-05 Option Award |
2023-01-09 4:59 pm |
N/A 2033-01-05 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
144,425 | $0 | 161,607 (Direct) |
View |
| 2023-01-06 Tax Withholding |
2023-01-09 4:59 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
1,719 | $27.52 | 161,607 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-10-13 4:03 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
1,464 | $56.9 | 124,098 (Direct) |
View |
| 2022-10-11 Option Award |
2022-10-13 4:03 pm |
N/A 2032-10-11 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
100,000 | $0 | 124,098 (Direct) |
View |
Ownership |
2022-10-11 4:01 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Cassidy James Chief Medical Officer |
0 | $0 | 137,398 (Direct) |
View |
| 2022-07-18 Tax Withholding |
2022-07-20 6:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,551 | $28.47 | 193,076 (Direct) |
View |
| 2022-07-18 Tax Withholding |
2022-07-20 6:02 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
3,103 | $28.47 | 49,584 (Direct) |
View |
| 2022-07-14 Option Award |
2022-07-15 06:07 am |
N/A 2032-07-14 |
SpringWorks Therapeutics Inc. | SWTX | ALBAN CARLOS Director |
40,218 | $0 | 40,218 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:30 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
6,092 | $0 | 194,627 (Direct) |
View |
| 2022-06-01 Tax Withholding |
2022-07-05 5:29 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
2,672 | $19.61 | 52,687 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 5:29 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Burgess Michael F. Head of Research & Development |
12,185 | $0 | 52,687 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 6:23 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director |
20,136 | $0 | 4,852,549 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:44 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner |
20,136 | $0 | 6,333,277 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:43 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
20,136 | $0 | 312,519 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:41 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director |
20,136 | $0 | 21,242 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:40 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director |
20,136 | $0 | 21,242 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:39 pm |
N/A 2032-05-19 |
SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director |
20,136 | $0 | 21,242 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:59 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
414 | $56.06 | 8,334 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:59 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
631 | $56.06 | 21,667 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
966 | $56.06 | 19,096 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Perier Francis I Jr Chief Financial Officer |
1,307 | $56.06 | 27,502 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,181 | $56.06 | 188,535 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:58 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
1,852 | $56.06 | 325,813 (Direct) |
View |
| 2022-01-07 Tax Withholding(A) |
2022-01-14 4:57 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
3,996 | $56.06 | 853,592 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-11 4:04 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel & Secretary |
1,323 | $56.06 | 18,739 (Direct) |
View |